Telix Pharmaceuticals files ADS shelf of indeterminate amount - F-3ASR (A$10.43, 0.00)
StreetAccount Summary - Trading higher/lower: Australia & New Zealand midday
Transcript Intelligence: Telix Pharmaceuticals Q4 Earnings Guidance
Transcript Intelligence: Telix Pharmaceuticals Q4 Earnings Q&A
Transcript Intelligence: Telix Pharmaceuticals Q4 Earnings Themes
StreetAccount Scorecard - Australian ASX200 short interest as at 12-Feb
StreetAccount Summary: Stocks reaching new 52-week highs/lows (210 total)
StreetAccount Summary: Australia and New Zealand Stocks reaching new 52-week highs/lows (38 total)
Powered by FactSet Research Systems Inc.